In this EM case's podcast, I've gathered together some of the most important adult and pediatric EM literature of 2016 from two great conferences.

North York General Hospital's 30th annual Emergency Medicine Update Emu Conference in Toronto and University of Toronto's Update in EM conference in Whistler.

We'll hear from Joel Yaffe, former U of TEM program director, who's been critically

appraising articles and practicing EM for more than 30 years, and he'll be discussing the pro-camio

study attached to antibiotics for abscesses, platelets for headbleeds, and workup of subarachnoid

hemorrhage. We'll hear from EM cases and first 10 EM's Justin Morganstern.

He'll give us his take on some of the studies that Joel covers, as well as dosing Ivy

Katorilak and the Pesit trial. And last but not least, we'll hear from Jason Fisher, chief at the

hospital for sick children in Toronto, will fly through ketamine dosing for sedation, instructions

after minor head injury,

Salter Harris 1 fractures of lateral maliolis, and interpreting oxygen saturations for disposition,

decision-making in kids with broncholitis.

Welcome to the Emergency Medicine Cases Podcast.

I'm your host, Dr. Anton Hellman, bringing you Canada's brightest minds in emergency medicine from EMC Studios in Toronto.

So this is a patient, 50 years old, comes in, he says he's got some palpitations.

Cardiogram is done, and when a cardiogram like this is done, usually everybody in the department gets involved in looking at it.

So everybody gets called around and you're looking at this cardiogram.

You say, what is it? What is it? What is it? What is it? And everybody decides that this is VTAC. And you go back to the patient. You have chest pain. No. Do you have shortness of breath? No. Are you okay? Keep saying okay. And he says, if you ask me any more times, I'm just going to say the same thing.

I feel fine.

So this person has stable VT. keep saying okay, and he says, if you ask me any more times, I'm just going to say the same thing.

I feel fine. So this person has stable VTAC. The guidelines, such as they are, for the management of stable VTAC, class both Amy O'Dorone and Procanamide, as class two recommendations for use for stable VTAC.

But there's really no evidence to support the benefit of one over the other.

...